Solicitation (RFP) F23-2516 – Wedgewood Suite M and N Expansion

Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires construction services for build-out of Wedgewood Suites M and N to expand the NCI at Frederick Central Repository operations. For information concerning opportunities with the FNLCR, please refer to: FNLCR Work with Us website: https://frederick.cancer.gov/collaborations/business-opportunities or contact the Leidos Biomedical Research Point of Contact listed in this announcement. Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD. Leidos Biomedical Research, Inc. POC: Subcontracts Administrator at [email protected]